Literature DB >> 1682736

Rapid diagnosis of hantavirus disease with an IgG-avidity assay.

K Hedman1, A Vaheri, M Brummer-Korvenkontio.   

Abstract

Nephropathia epidemica (NE), due to Puumala virus, is endemic in eastern Europe and Scandinavia. Serodiagnosis of NE relies on conventional indirect immunofluorescence to detect IgG against Puumala virus. However, in conventional serology, most patients with acute NE have raised but stable non-diagnostic antibody titres. For better serodiagnosis of NE, we have developed a test that measures the avidity (functional affinity) of IgG antibodies against Puumala virus. This new assay was highly specific and sensitive; a diagnosis of NE could be confirmed or excluded rapidly from an early single serum sample. With this test we have now verified the diagnosis of NE in more than 1300 Finnish patients during 22 months in 1989-91. Our findings point to an incidence of confirmed hantavirus disease much higher than previously shown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682736     DOI: 10.1016/0140-6736(91)92235-t

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

1.  Use of four dengue virus antigens for determination of dengue immune status by enzyme-linked immunosorbent assay of immunoglobulin G avidity.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Hantavirus and arenavirus antibody prevalence in rodents and humans in Trentino, Northern Italy.

Authors:  H Kallio-Kokko; J Laakkonen; A Rizzoli; V Tagliapietra; I Cattadori; S E Perkins; P J Hudson; A Cristofolini; W Versini; O Vapalahti; A Vaheri; H Henttonen
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

4.  Smoking is associated with aggravated kidney injury in Puumala hantavirus-induced haemorrhagic fever with renal syndrome.

Authors:  Laura Tervo; Satu Mäkelä; Jaana Syrjänen; Reetta Huttunen; Arja Rimpelä; Heini Huhtala; Olli Vapalahti; Antti Vaheri; Jukka Mustonen
Journal:  Nephrol Dial Transplant       Date:  2015-07-05       Impact factor: 5.992

5.  Reliability of four methods for the diagnosis of acute infection by Epstein-Barr virus.

Authors:  J Gutiérrez; M Rodríguez; C Maroto; G Piédrola
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

6.  Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue.

Authors:  Päivi Norja; Kati Hokynar; Leena-Maija Aaltonen; Renwei Chen; Annamari Ranki; Esa K Partio; Olli Kiviluoto; Irja Davidkin; Tomi Leivo; Anna Maria Eis-Hübinger; Beate Schneider; Hans-Peter Fischer; René Tolba; Olli Vapalahti; Antti Vaheri; Maria Söderlund-Venermo; Klaus Hedman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

7.  Avidity of antibody responses to Actinobacillus actinomycetemcomitans in periodontitis.

Authors:  D S O'Dell; J L Ebersole
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

8.  IgG avidity assay for estimation of the time after onset of hantavirus infection in colonized and wild bank voles.

Authors:  I Gavrilovskaya; N Apekina; N Okulova; V Demina; A Bernshtein; Y Myasnikov
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Antigenic characterization of Hantaan and Seoul virus nucleocapsid proteins expressed by recombinant baculovirus: application of a truncated protein, lacking an antigenic region common to the two viruses, as a serotyping antigen.

Authors:  M Morii; K Yoshimatsu; J Arikawa; G Zhou; H Kariwa; I Takashima
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Anti-endothelial cell antibodies in nephropathia epidemica and other viral diseases.

Authors:  A G Wangel; M Temonen; M Brummer-Korvenkontio; A Vaheri
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.